Ranked by reported Q1 2026 13F market value
Share of total reported institutional value in NVCT held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | BlackRock, Inc. | 764K | $5.9M | -2.4% | 2.882% | 0.00% |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 660K | $5.1M | β | 2.488% | 0.00% |
| 3 | IRIDIAN ASSET MANAGEMENT LLC/CT | 652K | $5.0M | +11.2% | 2.457% | 2.04% |
| 4 | Occam Crest Management LP | 407K | $3.1M | +7.1% | 1.535% | 1.96% |
| 5 | GEODE CAPITAL MANAGEMENT, LLC | 384K | $3.0M | +5.5% | 1.448% | 0.00% |
| 6 | BALDWIN BROTHERS INC/MA | 379K | $2.9M | -2.8% | 1.427% | 0.21% |
| 7 | STATE STREET CORP | 167K | $1.3M | +7.7% | 0.628% | 0.00% |
| 8 | NORTHERN TRUST CORP | 124K | $960K | +6.7% | 0.468% | 0.00% |
| 9 | VANGUARD FIDUCIARY TRUST CO | 115K | $888K | β | 0.433% | 0.00% |
| 10 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 105K | $814K | -45.9% | 0.397% | 0.00% |
| 11 | VANGUARD PORTFOLIO MANAGEMENT LLC | 92K | $712K | β | 0.347% | 0.00% |
| 12 | CITADEL ADVISORS LLC | 78K | $606K | β | 0.296% | 0.00% |
| 13 | OPPENHEIMER & CO INC | 74K | $569K | 0.0% | 0.277% | 0.01% |
| 14 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 50K | $384K | +12.8% | 0.187% | 0.00% |
| 15 | GOLDMAN SACHS GROUP INC | 41K | $318K | +55.2% | 0.155% | 0.00% |
| 16 | UBS Group AG | 39K | $298K | +360.4% | 0.145% | 0.00% |
| 17 | Bank of New York Mellon Corp | 30K | $234K | -4.2% | 0.114% | 0.00% |
| 18 | MARSHALL WACE, LLP | 29K | $226K | β | 0.110% | 0.00% |
| 19 | CIBC Bancorp USA Inc. | 26K | $198K | β | 0.097% | 0.00% |
| 20 | EverSource Wealth Advisors, LLC | 3K | $176K | β | 0.011% | 0.01% |
| 21 | MORGAN STANLEY | 23K | $174K | -19.4% | 0.085% | 0.00% |
| 22 | Austin Wealth Management, LLC | 20K | $154K | 0.0% | 0.076% | 0.03% |
| 23 | MARTINGALE ASSET MANAGEMENT L P | 18K | $139K | β | 0.068% | 0.00% |
| 24 | Nuveen, LLC | 17K | $129K | 0.0% | 0.063% | 0.00% |
| 25 | EDMOND DE ROTHSCHILD HOLDING S.A. | 15K | $117K | 0.0% | 0.057% | 0.00% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). β% of Fundβ shows how much of that investorβs total 13F portfolio is invested in NVCT β a direct measure of their conviction.
Filings activity in NVCT during Q1 2026, grouped by how each filer changed its position.
8 quarters of 13F filings Β· Ξ columns show change vs prior quarter
| Quarter | Inst. Holders | Ξ Holders | Ownership % | Ξ Ownership | Total 13F Value | Ξ Value |
|---|---|---|---|---|---|---|
| Q1 2026 | 59 | +26% | 12.15% | +0.87 pp | $35M | +7.7% |
| Q4 2025 | 47 | 11% | 11.28% | +3.60 pp | $32M | +47% |
| Q3 2025 | 53 | +15% | 7.68% | 0.67 pp | $22M | 8.1% |
| Q2 2025 | 46 | +44% | 8.35% | +1.65 pp | $24M | +25% |
| Q1 2025 | 32 | +3.2% | 6.70% | +4.37 pp | $19M | +187% |
| Q4 2024 | 31 | +0.0% | 2.33% | +0.23 pp | $7M | +11% |
| Q3 2024 | 31 | 23% | 2.10% | 0.32 pp | $6M | 13% |
| Q2 2024 | 40 | β | 2.42% | β | $7M | β |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Ξ columns compare to the immediately prior filed quarter.
Quick answers to the most common questions about buying NVCT stock.
Based on Q1 2026 13F filings, institutional ownership of Nuvectis Pharma, Inc. stands at 12.2%, held across 59 reporting institutions.
BlackRock, Inc. is the largest reported institutional holder of NVCT, with approximately 764,441 shares worth $0.01B as of Q1 2026.
Yes β 2 widely-followed marquee investors appear among the top 25 institutional holders of NVCT, including SUSQUEHANNA INTERNATIONAL GROUP, LLP, CITADEL ADVISORS LLC.
Our composite Smart Money Score for NVCT is 70 out of 100 (Bullish). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
16 institutions opened new positions in NVCT during Q1 2026, while 4 fully exited. 32 added to existing positions and 10 trimmed.
NVCT institutional ownership rose by 0.87 percentage points quarter-over-quarter, with a net change of +12 holders.
The top 10 institutions account for 84.1% of all reported 13F value in NVCT, and the top 25 account for 97.0%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
Nuvectis Pharma, Inc. (NVCT) Institutional Ownership